HR 3810
118th Congress
House
Health
Consumer affairs
Government information and archives
Manufacturing
Prescription drugs
Drug Origin Transparency Act of 2023
Introduced: June 5, 2023
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 9, 2023
Referred to the Subcommittee on Health.
Jun 5, 2023
Referred to the House Committee on Energy and Commerce.
Jun 5, 2023
Introduced in House
Plain-English summary
Drug Origin Transparency Act of 2023
This bill requires drug manufacturers to report on the suppliers of ingredients used in their products.
Specifically, drug manufacturers must report information relating to the supply chain of their products, including the suppliers of active ingredients and the amount of drugs that are manufactured using those ingredients. Drug manufacturers must also include information about the manufacturers of ingredients on the labels of their products.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2